Global Ion Channel Modulators Market Share, Supply, Analysis and Forecast to 2025

Press Release

A new market study, titled “2019 Global and Regional Ion Channel Modulators Market Research Report Forecast 2025”, has been featured on WiseGuyReports.

Report Description:

Ion channels are pore-forming membrane proteins. In these channels, a few drugs can directly or indirectly interact leading to a change in action potentials and other electrical signals all across the membrane. These channels are highly important for life and play a key role in various physiological processes like muscle contraction and nutrient transport. A host of diseases arise from the disruption of normal ion channel function. Channelophathies are referred to as the disorders that result from a mutation in the gene encoding. Some of the common channelophathies are long QT syndrome, cystic fibrosis, and epilepsy. Also, it is worth noting that ion channels are also involved in non-genetic diseases like diarrhea.

Ion channels are extremely molecularly diverse. For instance, more than 50 potassium channel subtypes are there, among which there are many for whose there are no particular pharmacological agents known. For specific ion channels, there exists a huge demand for activators and inhibitors that are essentially key players in some diseases or syndromes. Add to this, there a number of drugs available in the market that function primarily through the modulation of some specific ion channels. Ion channels represent a key pharmaceutical target for a wide pool of imperative clinical needs. The report on the global ion channel modulators market revealed the growth to be at a notable pace. The valuation of the ion channel modulators market was further stated to surpass its previous valuation. The increasing need for clinical efficiency and advancements in the healthcare sector are expected to be the biggest growth drivers of the market in the forthcoming years of the forecast period.

Request Free Sample Report at:

Global Ion Channel Modulators Market Research Report: Market Segmentation

The global ion channel modulators market has been segmented in terms of type and applications.

By type, the market is segmented into channel blockers and channel openers.

By application, the market divides into hospital, clinical trials, and others. The hospital segment of the market is expected to gain recognizable growth in the coming years. Whereas, the clinical trials segment is projected to be among the fastest growing in the global market for ion channel modulators.

Global Ion Channel Modulators Market Research Report: Regional Analysis

The global ion channel modulators market is geographically distributed across the following key regions: China, India, North America, Europe, and Southeast Asia. The North American regional market is gaining notable growth and is expected to stand out as one of the leading geographical areas under this market. The Indian and Chinese regional market of ion channel modulators are some of the other key regions that stands out due to their potential. The European region is a highly lucrative area for the ion channel modulators market and is expected to proliferate even further in the coming years.

View Detailed Report at :

Regionally, this report categorizes the production, apparent consumption, export and import of Ion Channel Modulators in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ion Channel Modulators manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer, Inc. (US)
Neusentis, Inc. (US)
AstraZeneca (UK)
Aurora Biomed, Inc. (Canada)
CalciMedica, Inc. (US)
Cellectricon AB (Sweden)
Convergence Pharmaceuticals Limited (UK)
Cytocentrics AG (Germany)
Evotec AG (Germany)
flyion GmbH (Germany)
GlaxoSmithKline Plc. (UK)
Nanion Technologies GmbH (Germany)
NeuroSearch A/S (Denmark)
Novartis AG (Switzerland)
Parion Sciences, Inc. (US)
Sanofi (France)
Targacept, Inc. (US)
Xention Limited (UK)
Zalicus, Inc. (US)

Segment by Regions
North America
Southeast Asia

Segment by Type
Channel Blockers
Channel Openers

Segment by Application
Clinical Trials

For more information or any query mail at [email protected]

About us:

Wise Guy Reports are a part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the global.

Contact Us:


[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)